Cancer remains one of Spain’s greatest public health challenges. According to the latest figures from the National Statistics Institute, tumours were responsible for 116,161 deaths in 2025. In total, Spain recorded 441,270 deaths that year. This means cancer accounted for more than one in four deaths nationwide, representing 26.3% of all fatalities.
Spain Expat Press Editorial Team
The figures confirm the continued pressure cancer places on Spain’s healthcare system. It remains the country’s leading cause of death. Yet there is also a more encouraging side to the story: while diagnoses continue to rise, survival rates are improving thanks to research, screening programmes and advances in treatment.
For 2026, the Spanish Society of Medical Oncology expects 301,184 new cancer diagnoses in Spain. This represents an increase of around two per cent compared with 2025. Part of this rise can be explained by the ageing population, but also by improved diagnostic tools and wider access to screening.
Among the tumours causing the highest number of deaths in Spain are lung and bronchial cancer, as well as bowel cancer. In 2025, lung and bronchial cancer caused 23,479 deaths, 0.9% more than in 2024.
Bowel cancer was responsible for 10,610 deaths, a rise of 1.5% compared with the previous year
Bowel cancer remains one of the most common forms of cancer among the Spanish population. Around 44,132 new cases of colorectal cancer are expected in 2026. This places it ahead of breast cancer, lung cancer, prostate cancer and bladder cancer. At the same time, the data suggest that some types of cancer, including bowel and lung cancer, may be stabilising or even slightly declining among men.
To understand the scale of the issue, it is important to distinguish between incidence and prevalence. Incidence refers to the number of new cases diagnosed within a specific period. Prevalence, by contrast, indicates how many people are living with cancer at a given point in time, regardless of when they were first diagnosed.
According to the Cancer Observatory of the Spanish Association Against Cancer, Spain’s cancer incidence in 2024 stood at 597 new diagnoses per 100,000 inhabitants. This places Spain at a similar level to Europe as a whole, where the average was 569 cases per 100,000 inhabitants in 2022.
The regional differences are particularly striking
Spain’s Epidemiological Cancer Information System, known as SIEC, was presented in October 2025. It is regarded as the first official system designed to bring together up-to-date cancer data in Spain in a systematic way. Early data pointed to high prevalence in regions such as Catalonia and Andalusia. However, fully harmonised figures are still not available for all autonomous communities.
The highest levels of both incidence and mortality in 2024 were recorded in Asturias, Castile and León, and Galicia. These three regions therefore stand out as the areas most affected by cancer in Spain.One key factor is likely to be demographics. Asturias, Castile and León, and Galicia are among the regions with comparatively older populations. Since the risk of developing cancer rises with age, the age structure of these regions has a direct impact on the number of diagnoses and deaths.
At the other end of the scale are the Balearic Islands, Murcia, and the autonomous cities of Ceuta and Melilla. These areas show comparatively lower levels of both cancer incidence and mortality. This may be linked to a younger population structure, different lifestyle patterns, variations in risk factors or differences in early detection.
Madrid also stands out
In the capital region, mortality is comparatively lower in relation to cancer incidence. This could point to a denser hospital network, faster access to specialist treatment and more effective early detection.
When it comes to the most common tumour type, the pattern is similar across much of Spain. Bowel cancer is the most frequently diagnosed cancer in most autonomous communities. Cantabria is a notable exception, where lung cancer ranks first.
Despite the scale of the challenge, cancer mortality in Spain remains below the European average
According to the Cancer Observatory of the Spanish Association Against Cancer, Spain’s mortality rate stands at 227, compared with a European average of 263.
The differences between regions cannot be explained by a single cause. Factors include the average age of the population, tobacco use, diet, lack of physical activity, obesity, access to screening programmes, the speed of diagnosis and the availability of healthcare resources.
Experts stress that reducing cancer mortality does not depend solely on better treatments. Prevention, healthier lifestyles, regular check-ups and early diagnosis are also crucial. In many types of cancer, detecting the disease early can significantly change the course of treatment and survival.
Spain is therefore facing a complex public health challenge
More cancer cases are being diagnosed, yet many patients are living longer after diagnosis. Cancer remains one of the most feared diseases, but medicine is making progress. Prevention and early detection remain two of the most powerful tools in the fight against it.
